STX1B and Parkinson disease: A more recent two-stage meta-analysis performed by the IPDGC and the Wellcome Trust Case Control Consortium 2 (WTCCC2) revealed five additional loci associated with PD risk (PARK16/1q32, STX1B, GWA 8p22, STBD1, GPNMB) [68].